Daniel Jackson

Daniel Jackson is a dedicated professional in the healthcare industry with over 20 years of experience, currently serving as the Global Head of Market Access Policy at UCB, a renowned biopharmaceutical company specializing in severe diseases in immunology and neurology.

Daniel's passion lies in making a positive impact on people's lives through effective care and innovative solutions. He believes in the power of understanding the patient's perspective to drive meaningful change and improve quality of life.

With a strong educational background including a PhD from the University of Surrey, an MSc from the University of York, and executive education from esteemed institutions like Harvard Business School and IMD Business School, Daniel has honed his expertise in healthcare management and market access.

Throughout his career, Daniel has held key leadership roles in prestigious organizations such as Edwards Lifesciences, Alcon Laboratories, Inc., and GE Healthcare, where he managed market access, health economics, and public affairs functions.

As a firm advocate for teamwork and diversity, Daniel emphasizes the importance of creating an inclusive work environment where individual skills are celebrated, fostering strong and agile teams that drive sustainable growth and serve patients effectively.

Daniel's commitment to enabling patients to achieve their goals, coupled with his dedication to developing high-performing teams, underscores his unwavering dedication to making a positive difference in the healthcare sector.